United States · Series A startup

Who invested in BreachRx

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Cybersecurity

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2025, from 1 source

Latest round
Series A, $15MMay 2025
Investors
4
See who backed them

The rounds

  1. May 2025

Founders and team

From BreachRx's own website and the SEC filings it signed: 7 on the team.

  • John ZilinskasChief Revenue Officer
  • Matt HartleyChief Product Officer
  • Stephen GarciaChief Information Security Officer
  • Young-Sae SongChief Marketing Officer
  • Cody WamsleyVP & General Counsel
  • Anderson LunsfordExecutive Officer, Directori
  • Matthew HartleyExecutive Officer, Directori

On the board, as filediSean O'Brien

Everyone who backed them

Alchemist AcceleratorAccelerator1round
Ballistic VenturesVC firm1round
SYN VenturesVC firm1round
OverlineVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about BreachRx

Who invested in BreachRx?

BreachRx's investors include Alchemist Accelerator, Ballistic Ventures, SYN Ventures and Overline.

How much has BreachRx raised?

BreachRx has raised $15M across 1 round since 2025.

When did BreachRx last raise?

BreachRx's most recent round was a Series A of $15M in May 2025.

What was BreachRx's biggest round?

Its most recent round, $15M in May 2025, is also its largest on record.

Who backed BreachRx first?

BreachRx's first round on record, in May 2025, was backed by Alchemist Accelerator, Ballistic Ventures and SYN Ventures and 1 others.

What stage is BreachRx at?

BreachRx's latest named round is a Series A, in May 2025.

Where is BreachRx based?

BreachRx is based in the United States.

Companies like BreachRx

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.